Methicillin-resistant Staphylococcus aureus infections

Med Clin North Am. 2013 Jul;97(4):601-19, x. doi: 10.1016/j.mcna.2013.02.005.

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is an important pathogen that has exploded into clinical prominence in a short period. New medications are available for the treatment of MRSA infections, each with its own pitfalls and caveats. However, the resistance profile of the bacteria is becoming more complex. Recent guidelines from the Infectious Diseases Society of America provide an evidence-based framework for the management of MRSA infections. This article provides additional practical advice on approaches to MRSA, including the detection, prevention, and management of a variety of its common presentations.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Community-Acquired Infections / diagnosis
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / etiology
  • Community-Acquired Infections / prevention & control
  • Cross Infection / diagnosis
  • Cross Infection / drug therapy
  • Cross Infection / etiology
  • Cross Infection / prevention & control
  • Humans
  • Methicillin-Resistant Staphylococcus aureus*
  • Recurrence
  • Risk Factors
  • Staphylococcal Infections* / diagnosis
  • Staphylococcal Infections* / drug therapy
  • Staphylococcal Infections* / etiology
  • Staphylococcal Infections* / prevention & control

Substances

  • Anti-Bacterial Agents